STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo

Cell Growth and Differentiation

Volumn 13, Issue 8, 2002, Pages 355-362

  Kijima, Taro ^a   Niwa, Hideo ^a   Steinman, Richard A ^a   Drenning, Stephanie D ^a   Gooding, William E ^a   Wentzel, Abbey L ^a   Xi, Sichuan ^a   Grandis, Jennifer Rubin ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; PROTEIN BCL XL; STAT3 PROTEIN; BCL2L1 PROTEIN, HUMAN; DNA BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; PROTEIN BCL 2; PROTEIN BCL X; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CELL ACTIVATION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GROWTH RATE; GROWTH REGULATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; CELL CULTURE; CELL DIVISION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PATHOPHYSIOLOGY;

AUTOCRINE COMMUNICATION; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DIVISION; CYCLIN D1; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMAN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; BCL-X PROTEIN; HUMANS; STAT3 TRANSCRIPTION FACTOR;

EID: 0036024855     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
2. Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
3. Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice
4. Stimulation by EGF of the growth of EGF receptor-hyperproducing tumor cells in athymic mice
5. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival
6. Downmodulation of TGF-α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells
7. EGF receptor deletions define a region specifically mediating STAT transcription factor activation
8. STATs: Signal transducers and activators of transcription
9. STATs and gene regulation
10. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
11. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts
12. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
13. Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway
14. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells
15. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
16. Requirement of Stat3 but not Stat1 for EGFR-mediated cell growth in vitro
17. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
18. Stat3 as an oncogene
19. Both Stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6-induced apoptosis of 1A9-M cells
20. Epidermal growth factor receptor-mediated Stat3 signaling blocks apoptosis in head and neck cancer
21. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
22. STATs in oncogenesis
23. STAT proteins: Novel molecular targets for cancer drug discovery
24. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1
25. Kip1 for restriction point control of the fibroblast cell cycle
26. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases
27. STAT signaling in head and neck cancer
28. Targeting growth factor receptors: Integration of novel therapeutics in the management of head and neck cancer
29. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer
30. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines
31. Modulation of growth, differentiation and glycoprotein synthesis by b-all-trans retinoic acid in a multicellular tumor spheroid model for squamous cell carcinoma of the head and neck
32. Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by b-all-trans retinoic acid
33. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
34. A unique palindromic element mediates gamma interferon induction of mig gene expression
35. The SIF binding element confers sis/pdgf inducibility onto the c-fos promoter
36. Semiparametric models for longitudinal data with application to CD4 cell numbers in HIV seroconverters